Eden Research has considerably expanded its end market opportunity portfolio during the pandemic, such that we now see four potential growth drivers, the core products (including launch in the US), terpene-based insecticide, seed treatments and the Sustaine microencapsulation development. We believe these products are targeting substantial markets and could deliver significant returns in the medium term. With this report, we have reintroduced forecasts for Eden Research, conservatively built upo ....
03 Mar 2022
Cenkos: Eden Research Plc -- Expanded opportunities
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Eden Research Plc -- Expanded opportunities
Eden Research plc (EDEN:LON) | 4.8 0 0.0% | Mkt Cap: 25.9m
- Published:
03 Mar 2022 -
Author:
Chris Donnellan -
Pages:
70
Eden Research has considerably expanded its end market opportunity portfolio during the pandemic, such that we now see four potential growth drivers, the core products (including launch in the US), terpene-based insecticide, seed treatments and the Sustaine microencapsulation development. We believe these products are targeting substantial markets and could deliver significant returns in the medium term. With this report, we have reintroduced forecasts for Eden Research, conservatively built upo ....